Literature DB >> 15725582

Dystroglycan: important player in skeletal muscle and beyond.

Ronald D Cohn1.   

Abstract

Dystroglycan is a transmembrane protein that connects the extracellular matrix to the cytoskeleton. Given the ubiquitous tissue expression of dystroglycan, different functional roles in various organ systems have been characterized during the past decade. More recently, aberrant glycosylation of dystroglycan has been identified as a novel pathogenetic mechanism in several forms of congenital and late onset muscular dystrophy syndromes. The current review summarizes the recent scientific achievements as they relate to the function of dystroglycan under normal and pathophysiological conditions.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15725582     DOI: 10.1016/j.nmd.2004.11.005

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  25 in total

1.  Site mapping and characterization of O-glycan structures on alpha-dystroglycan isolated from rabbit skeletal muscle.

Authors:  Stephanie H Stalnaker; Sana Hashmi; Jae-Min Lim; Kazuhiro Aoki; Mindy Porterfield; Gerardo Gutierrez-Sanchez; James Wheeler; James M Ervasti; Carl Bergmann; Michael Tiemeyer; Lance Wells
Journal:  J Biol Chem       Date:  2010-05-27       Impact factor: 5.157

Review 2.  Decoding arenavirus pathogenesis: essential roles for alpha-dystroglycan-virus interactions and the immune response.

Authors:  Michael B A Oldstone; Kevin P Campbell
Journal:  Virology       Date:  2010-12-23       Impact factor: 3.616

3.  Old World arenavirus infection interferes with the expression of functional alpha-dystroglycan in the host cell.

Authors:  Jillian M Rojek; Kevin P Campbell; Michael B A Oldstone; Stefan Kunz
Journal:  Mol Biol Cell       Date:  2007-08-29       Impact factor: 4.138

Review 4.  Extracellular matrix and its receptors in Drosophila neural development.

Authors:  Kendal Broadie; Stefan Baumgartner; Andreas Prokop
Journal:  Dev Neurobiol       Date:  2011-11       Impact factor: 3.964

5.  Dissecting muscle and neuronal disorders in a Drosophila model of muscular dystrophy.

Authors:  Halyna R Shcherbata; Andriy S Yatsenko; Larissa Patterson; Vanita D Sood; Uri Nudel; David Yaffe; David Baker; Hannele Ruohola-Baker
Journal:  EMBO J       Date:  2007-01-11       Impact factor: 11.598

6.  Dystroglycan is not required for maintenance of the luminal epithelial basement membrane or cell polarity in the mouse prostate.

Authors:  Alison K Esser; Michael B Cohen; Michael D Henry
Journal:  Prostate       Date:  2010-05-15       Impact factor: 4.104

Review 7.  Other model organisms for sarcomeric muscle diseases.

Authors:  John Sparrow; Simon M Hughes; Laurent Segalat
Journal:  Adv Exp Med Biol       Date:  2008       Impact factor: 2.622

8.  Functional glycosylation of dystroglycan is crucial for thymocyte development in the mouse.

Authors:  Li-Ying Liou; Kevin B Walsh; Arineh R Vartanian; Daniel Beltran-Valero de Bernabe; Megan Welch; Kevin P Campbell; Michael B A Oldstone; Stefan Kunz
Journal:  PLoS One       Date:  2010-03-29       Impact factor: 3.240

9.  Computer-aided visualization of muscle weakness distribution.

Authors:  Allan J Pieterse; Nicol C Voermans; Hans S Tuinenga; Baziel G M van Engelen
Journal:  J Neurol       Date:  2008-09-03       Impact factor: 4.849

10.  Zebrafish models for human FKRP muscular dystrophies.

Authors:  Genri Kawahara; Jeffrey R Guyon; Yukio Nakamura; Louis M Kunkel
Journal:  Hum Mol Genet       Date:  2009-12-01       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.